The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The human gene symbol CYC1 in this request corresponds to cytochrome c1, a heme c1–containing catalytic/core subunit of mitochondrial respiratory chain complex III (cytochrome bc1; ubiquinol:cytochrome c oxidoreductase), consistent with UniProt accession P08574. This mapping is supported by both a high-confidence human genetics study and a 2024 expert update on nuclear genes causing complex III deficiency. (gaignard2013mutationsincyc1 pages 1-2, cunatova2024pathologicalvariantsin pages 4-5)
Complex III (CIII) is a central inner-mitochondrial-membrane (IMM) enzyme complex of oxidative phosphorylation (OXPHOS). It transfers electrons from ubiquinol (QH2) to the mobile electron carrier cytochrome c, while contributing to the proton gradient by moving protons to the intermembrane space (IMS) via the Q-cycle mechanism; CIII operates as an obligate homodimer (CIII2). (kohler2023thefunctionalsignificance pages 1-2)
In the Q-cycle, quinol oxidation at the Qo site yields two electrons that split into two paths. One electron transfers from Qo to the Rieske 2Fe–2S center, then to cytochrome c1, then to cytochrome c. The other electron proceeds through cytochrome b’s hemes toward the Qi site, supporting quinone reduction, while quinol oxidation at Qo is coupled to proton release into the IMS. (bochkova2025theflexiblechain pages 8-9, kohler2023thefunctionalsignificance pages 1-2)
CYC1 encodes cytochrome c1, the heme-containing complex III subunit that provides the heme c1 redox cofactor used to accept electrons (from the Rieske protein) and donate them to soluble cytochrome c on the IMS side. (bochkova2025theflexiblechain pages 8-9, osz2025mutationsofthe pages 4-6)
CYC1’s gene product (cytochrome c1) is not an independent metabolic enzyme in isolation; its primary function is as an electron-transfer subunit within complex III.
Mechanistically, cytochrome c1:
- accepts electrons from the Rieske 2Fe–2S protein during the Q-cycle, and
- donates electrons to cytochrome c for delivery to complex IV. (bochkova2025theflexiblechain pages 8-9)
Cytochrome c1 contains an exposed heme c1 that supports rapid electron transfer to cytochrome c. A recent biophysical review summarizes the cytochrome c–cytochrome c1 encounter geometry as ~17.4 Å Fe-to-Fe (≈9.4 Å edge-to-edge) and reports predicted electron-transfer rates up to ~8.3 × 10^6 s−1, consistent with short-range heme-to-heme tunneling requirements. (bochkova2025theflexiblechain pages 9-11)
Human cytochrome c1 is an IMM protein with its functional (heme-containing) domain facing the intermembrane space, consistent with its role donating electrons to soluble cytochrome c in the IMS. The disease genetics study describing pathogenic CYC1 variants explicitly notes the protein is anchored by a single C-proximal transmembrane segment and places the heme-bearing domain on the IMS side. (gaignard2013mutationsincyc1 pages 1-2)
CYC1 is synthesized in the cytosol as a precursor and imported post-translationally into mitochondria. A CYC1-associated disease report states cytochrome c1 matures after two cleavage episodes, consistent with multi-step processing of mitochondrial inner-membrane proteins. (heidari2021defectivecomplexiii pages 1-2)
A 2024 experimental/computational study (mouse Immp2lKD−/− knockout) provides evidence that IMMP2L, an inner mitochondrial membrane peptidase, is required to cleave and remove the signal/transit peptide from cytochrome c1 (Cyc1). In the knockout, uncleaved Cyc1 is detected and AlphaFold2-Multimer modeling predicts altered Cyc1–Cyb (cytochrome b) contacts, including 56 new contacts between the retained transit peptide and Cyb. The same study reports physiologic/functional correlates including reduced respiration in primary MEFs (~27% lower total respiration; ~12% lower mitochondrial respiration) and a ~31% reduction in succinate-driven kidney respiration, consistent with compromised respiratory-chain performance when Cyc1 processing is perturbed. (clarke2024immp2lenhancesthe pages 7-9, clarke2024immp2lenhancesthe pages 9-11, clarke2024immp2lenhancesthe pages 2-3)
As mechanistic context, a 2024 Cell Reports study in yeast describes a coordinated maturation environment where the IMMP2L homolog (Imp2) is linked to cytochrome c1 (Cyt1) processing after hemylation, supporting the general concept that cytochrome c1 cleavage is a regulated late maturation step rather than a trivial trimming event. (horten2024identificationofmimas pages 5-6)
CYC1 acts specifically within the electron transport chain (ETC) as part of complex III, connecting the membrane quinone pool (CoQ/QH2) to the cytochrome c pool, which then supplies electrons to complex IV. (kohler2023thefunctionalsignificance pages 1-2, ros2025bluntingmycfunction pages 7-11)
A 2023 EMBO Reports expert review emphasizes that ETC complexes can assemble into respiratory supercomplexes and discusses ongoing uncertainty about universal functional advantages; nevertheless, complex III’s dimeric architecture and Q-cycle role are central features around which supercomplex discussions are framed. This is relevant to CYC1 because cytochrome c1 provides the IMS-facing exit point for electrons to the mobile carrier cytochrome c, and the spatial organization of complex III relative to complex IV can shape effective electron transfer routes. (kohler2023thefunctionalsignificance pages 1-2)
A 2024 Journal of Inherited Metabolic Disease update (Čunátová & Fernández-Vizarra, published July 2024, URL: https://doi.org/10.1002/jimd.12751) consolidates current knowledge on nuclear genes causing complex III deficiency and lists CYC1 (OMIM 615453) as a core subunit gene with four reported cases/families. In the excerpted summary, the clinical pattern for CYC1 includes neonatal-to-childhood episodic metabolic decompensation, including ketoacidosis, lactic acidosis, and hyperammonemia; reported CYC1 variants include c.288G>T (p.Trp96Cys), c.643C>T (p.Leu215Phe), and c.949C>T (p.Arg317Trp). (cunatova2024pathologicalvariantsin pages 4-5)
A landmark study (Gaignard et al., American Journal of Human Genetics; published Aug 2013, URL: https://doi.org/10.1016/j.ajhg.2013.06.015) identifies homozygous p.Trp96Cys and p.Leu215Phe variants in children with recurrent metabolic crises and insulin-responsive hyperglycemia. The study reports markedly reduced cytochrome c1 protein and an isolated complex III enzymatic defect, with CIII-to-citrate-synthase activities measured at 4% (liver), 24% (muscle), and 25% (fibroblasts) of controls, and shows that expression of wild-type CYC1 restores complex III activity in patient cells (functional complementation). These data tightly connect CYC1 genotype to complex III biochemical phenotype, representing a clinically actionable diagnostic archetype (variant → enzyme defect → rescue). (gaignard2013mutationsincyc1 pages 1-2)
A 2021 case report (Mitochondrion; published Sep 2021, URL: https://doi.org/10.1016/j.mito.2021.07.001) reports a homozygous p.Arg317Trp variant and describes a complex III defect presenting with optic/white-matter features that can mimic inflammatory demyelination or optic neuropathy syndromes. This underscores a real-world diagnostic issue: CYC1-related mitochondrial disease can present outside “classic” metabolic phenotypes. (heidari2021defectivecomplexiii pages 1-2)
The following table summarizes CYC1 functional annotation, localization, processing, disease associations, and quantitative data points used in this report.
| Category | Key points | Best supporting citations |
|---|---|---|
| Identity/Complex membership | Human CYC1 (UniProt P08574) encodes cytochrome c1, a nuclear-encoded core catalytic subunit of mitochondrial respiratory chain complex III (cytochrome bc1 / ubiquinol:cytochrome c oxidoreductase). Complex III is an obligate homodimer in the inner mitochondrial membrane; cytochrome c1 is one of the three evolutionarily conserved catalytic subunits together with cytochrome b and the Rieske Fe-S protein. | (cunatova2024pathologicalvariantsin pages 4-5, gaignard2013mutationsincyc1 pages 1-2, ros2025bluntingmycfunction pages 7-11, kohler2023thefunctionalsignificance pages 1-2) |
| Catalytic role | CYC1 itself is not a standalone enzyme; within complex III it carries out the cytochrome c1 electron-transfer step of the Q-cycle. Electrons derived from ubiquinol (QH2) oxidation at the Qo site pass via the Rieske 2Fe-2S protein to heme c1 in cytochrome c1, then to soluble cytochrome c, while the second electron travels through cytochrome b hemes toward the Qi site. This helps couple electron transfer to proton release into the intermembrane space. | (bochkova2025theflexiblechain pages 8-9, bochkova2025theflexiblechain pages 9-11, kohler2023thefunctionalsignificance pages 1-2) |
| Cofactor | Cytochrome c1 contains a single c-type heme, heme c1, covalently attached and exposed for rapid electron transfer to cytochrome c. The 2024 complex III deficiency update describes CYC1 as bearing a heme-binding C-terminal domain facing the intermembrane space; earlier primary work identifies the mature protein as the heme-containing subunit of complex III. | (cunatova2024pathologicalvariantsin pages 4-5, gaignard2013mutationsincyc1 pages 1-2, osz2025mutationsofthe pages 4-6) |
| Localization/topology | CYC1 is a mitochondrial inner membrane protein. Its heme-containing domain projects into the intermembrane space, where it meets cytochrome c; the protein is anchored by a single C-proximal transmembrane segment. Thus, its functional redox surface is IMS-exposed while its anchor resides in the inner membrane. | (gaignard2013mutationsincyc1 pages 1-2, cunatova2024pathologicalvariantsin pages 4-5, ros2025bluntingmycfunctiona pages 7-11) |
| Processing/maturation | Cytochrome c1 is synthesized as a precursor, imported post-translationally into mitochondria, and matures after proteolytic processing. Evidence from CYC1 disease literature states the precursor undergoes two cleavage episodes before the mature heme-bound form is produced. IMMP2L is reported to cleave the CYC1 transit/signal peptide; in Immp2l-deficient mice, uncleaved Cyc1 accumulates and displays altered predicted interactions within complex III. Yeast biogenesis work further supports that cytochrome c1 cleavage occurs after hemylation in a dedicated maturation context. | (heidari2021defectivecomplexiii pages 1-2, clarke2024immp2lenhancesthe pages 2-3, horten2024identificationofmimas pages 5-6) |
| Key interactions | Functionally critical partners are UQCRFS1/Rieske Fe-S protein (upstream electron donor), cytochrome c (downstream mobile acceptor), and cytochrome b/CYB within the same complex. Structural/biophysical analysis indicates fast heme-to-heme transfer from heme c1 to cytochrome c via a short-distance docking interface shaped by electrostatic and hydrophobic contacts. IMMP2L-loss modeling predicts altered Cyc1-Cyb contacts when the transit peptide is retained. | (bochkova2025theflexiblechain pages 9-11, clarke2024immp2lenhancesthe pages 7-9, clarke2024immp2lenhancesthe pages 11-12) |
| Disease associations | Pathogenic biallelic CYC1 variants cause isolated complex III deficiency. Reported variants include p.Trp96Cys, p.Leu215Phe, and p.Arg317Trp. Phenotypes include recurrent ketoacidosis, lactic acidosis, hyperammonemia, insulin-responsive hyperglycemia, and in later reports mitochondrial leukoencephalopathy/optic neuropathy-like presentations. The 2024 update notes 4 reported cases/families. | (cunatova2024pathologicalvariantsin pages 4-5, gaignard2013mutationsincyc1 pages 1-2, heidari2021defectivecomplexiii pages 1-2, cunatova2024pathologicalvariantsin pages 11-12) |
| Recent developments 2023-2024 | Recent expert reviews emphasize complex III and supercomplex organization as central to respiratory efficiency and signaling. The 2024 JIMD update consolidates the current human genetic evidence for CYC1-related complex III deficiency. A 2024 IMMP2L study adds a newer maturation/regulatory angle by linking failed precursor cleavage to altered CYC1-CYB interactions and respiration defects, expanding understanding of how CYC1 processing may affect complex III performance beyond rare coding variants. | (cunatova2024pathologicalvariantsin pages 4-5, clarke2024immp2lenhancesthe pages 11-12, clarke2024immp2lenhancesthe pages 2-3, kohler2023thefunctionalsignificance pages 1-2) |
| Quantitative data points | Reported electron-transfer geometry for cytochrome c1 ↔ cytochrome c: ~17.4 Å Fe-to-Fe and ~9.4 Å edge-to-edge, with predicted transfer rates up to ~8.3 × 10^6 s^-1. In CYC1-deficient patients, complex III activity was reported at 4%, 24%, and 25% of controls in liver, muscle, and fibroblasts, respectively. In IMMP2L-deficient models affecting CYC1 processing, MEFs showed ~27% lower total respiration and ~12% lower mitochondrial respiration; kidney succinate-driven respiration was ~31% lower, and modeling predicted 56 new contacts between uncleaved Cyc1 transit peptide and Cyb. | (bochkova2025theflexiblechain pages 9-11, gaignard2013mutationsincyc1 pages 1-2, clarke2024immp2lenhancesthe pages 9-11, clarke2024immp2lenhancesthe pages 7-9) |
Table: This table summarizes the core functional annotation for human CYC1 (UniProt P08574), including its role in mitochondrial complex III, topology, maturation, disease relevance, and recent research highlights. It is designed as a compact evidence-backed reference for narrative reporting.
References
(gaignard2013mutationsincyc1 pages 1-2): Pauline Gaignard, Minal Menezes, Manuel Schiff, Aurélien Bayot, Malgorzata Rak, Hélène Ogier de Baulny, Chen-Hsien Su, Mylene Gilleron, Anne Lombes, Heni Abida, Alexander Tzagoloff, Lisa Riley, Sandra T. Cooper, Kym Mina, Padma Sivadorai, Mark R. Davis, Richard J.N. Allcock, Nina Kresoje, Nigel G. Laing, David R. Thorburn, Abdelhamid Slama, John Christodoulou, and Pierre Rustin. Mutations in cyc1, encoding cytochrome c1 subunit of respiratory chain complex iii, cause insulin-responsive hyperglycemia. American journal of human genetics, 93 2:384-9, Aug 2013. URL: https://doi.org/10.1016/j.ajhg.2013.06.015, doi:10.1016/j.ajhg.2013.06.015. This article has 92 citations and is from a highest quality peer-reviewed journal.
(cunatova2024pathologicalvariantsin pages 4-5): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 13 citations and is from a peer-reviewed journal.
(kohler2023thefunctionalsignificance pages 1-2): Andreas Kohler, Antoni Barrientos, Flavia Fontanesi, and Martin Ott. The functional significance of mitochondrial respiratory chain supercomplexes. EMBO Reports, Oct 2023. URL: https://doi.org/10.15252/embr.202357092, doi:10.15252/embr.202357092. This article has 90 citations and is from a highest quality peer-reviewed journal.
(bochkova2025theflexiblechain pages 8-9): Z. Bochkova, Adil A. Baizhumanov, A. Yusipovich, Kseniia I Morozova, E. Nikelshparg, Anna A Fedotova, Alisa Tiaglik, Yu Xu, Alexey R. Brazhe, Georgy V Maksimov, Dmitry S. Bilan, Yuliya V. Khramova, E. Y. Parshina, and N. Brazhe. The flexible chain: regulation of structure and activity of etc complexes defines rate of atp synthesis and sites of superoxide generation. Biophysical reviews, 17 1:55-88, Jan 2025. URL: https://doi.org/10.1007/s12551-025-01270-5, doi:10.1007/s12551-025-01270-5. This article has 16 citations and is from a peer-reviewed journal.
(osz2025mutationsofthe pages 4-6): Fanni Ősz, Aamir Nazir, Krisztina Takács-Vellai, and Zsolt Farkas. Mutations of the electron transport chain affect lifespan and ros levels in c. elegans. Antioxidants, 14:76, Jan 2025. URL: https://doi.org/10.3390/antiox14010076, doi:10.3390/antiox14010076. This article has 14 citations.
(bochkova2025theflexiblechain pages 9-11): Z. Bochkova, Adil A. Baizhumanov, A. Yusipovich, Kseniia I Morozova, E. Nikelshparg, Anna A Fedotova, Alisa Tiaglik, Yu Xu, Alexey R. Brazhe, Georgy V Maksimov, Dmitry S. Bilan, Yuliya V. Khramova, E. Y. Parshina, and N. Brazhe. The flexible chain: regulation of structure and activity of etc complexes defines rate of atp synthesis and sites of superoxide generation. Biophysical reviews, 17 1:55-88, Jan 2025. URL: https://doi.org/10.1007/s12551-025-01270-5, doi:10.1007/s12551-025-01270-5. This article has 16 citations and is from a peer-reviewed journal.
(heidari2021defectivecomplexiii pages 1-2): Erfan Heidari, Maryam Rasoulinezhad, Neda Pak, Mahmoud Reza Ashrafi, Morteza Heidari, Brenda Banwell, Masoud Garshasbi, and Ali Reza Tavasoli. Defective complex iii mitochondrial respiratory chain due to a novel variant in cyc1 gene masquerades acute demyelinating syndrome or leber hereditary optic neuropathy. Sep 2021. URL: https://doi.org/10.1016/j.mito.2021.07.001, doi:10.1016/j.mito.2021.07.001. This article has 8 citations and is from a peer-reviewed journal.
(clarke2024immp2lenhancesthe pages 7-9): Raymond A. Clarke, Hemna Govindaraju, Martina Beretta, Ellen Olzomer, Adam J. Lawther, Adam K. Walker, Zhiming Fang, Valsamma Eapen, Tzipi Cohen Hyams, Murray Killingsworth, Wallace Bridge, Nigel Turner, and Khawar Sohail Siddiqui. Immp2l enhances the structure and function of mitochondrial gpd2 dehydrogenase. International Journal of Molecular Sciences, 25:990, Jan 2024. URL: https://doi.org/10.3390/ijms25020990, doi:10.3390/ijms25020990. This article has 3 citations.
(clarke2024immp2lenhancesthe pages 9-11): Raymond A. Clarke, Hemna Govindaraju, Martina Beretta, Ellen Olzomer, Adam J. Lawther, Adam K. Walker, Zhiming Fang, Valsamma Eapen, Tzipi Cohen Hyams, Murray Killingsworth, Wallace Bridge, Nigel Turner, and Khawar Sohail Siddiqui. Immp2l enhances the structure and function of mitochondrial gpd2 dehydrogenase. International Journal of Molecular Sciences, 25:990, Jan 2024. URL: https://doi.org/10.3390/ijms25020990, doi:10.3390/ijms25020990. This article has 3 citations.
(clarke2024immp2lenhancesthe pages 2-3): Raymond A. Clarke, Hemna Govindaraju, Martina Beretta, Ellen Olzomer, Adam J. Lawther, Adam K. Walker, Zhiming Fang, Valsamma Eapen, Tzipi Cohen Hyams, Murray Killingsworth, Wallace Bridge, Nigel Turner, and Khawar Sohail Siddiqui. Immp2l enhances the structure and function of mitochondrial gpd2 dehydrogenase. International Journal of Molecular Sciences, 25:990, Jan 2024. URL: https://doi.org/10.3390/ijms25020990, doi:10.3390/ijms25020990. This article has 3 citations.
(horten2024identificationofmimas pages 5-6): Patrick Horten, Kuo Song, Joshua Garlich, Robert Hardt, Lilia Colina-Tenorio, Susanne E. Horvath, Uwe Schulte, Bernd Fakler, Martin van der Laan, Thomas Becker, Rosemary A. Stuart, Nikolaus Pfanner, and Heike Rampelt. Identification of mimas, a multifunctional mega-assembly integrating metabolic and respiratory biogenesis factors of mitochondria. Cell Reports, 43:113772, Mar 2024. URL: https://doi.org/10.1016/j.celrep.2024.113772, doi:10.1016/j.celrep.2024.113772. This article has 9 citations and is from a highest quality peer-reviewed journal.
(ros2025bluntingmycfunction pages 7-11): O Ros. Blunting myc function in mitochondrial complex iii deficient mice with a hypomorphic myc allele. Unknown journal, 2025.
(ros2025bluntingmycfunctiona pages 7-11): O Ros. Blunting myc function in mitochondrial complex iii deficient mice with a hypomorphic myc allele. Unknown journal, 2025.
(clarke2024immp2lenhancesthe pages 11-12): Raymond A. Clarke, Hemna Govindaraju, Martina Beretta, Ellen Olzomer, Adam J. Lawther, Adam K. Walker, Zhiming Fang, Valsamma Eapen, Tzipi Cohen Hyams, Murray Killingsworth, Wallace Bridge, Nigel Turner, and Khawar Sohail Siddiqui. Immp2l enhances the structure and function of mitochondrial gpd2 dehydrogenase. International Journal of Molecular Sciences, 25:990, Jan 2024. URL: https://doi.org/10.3390/ijms25020990, doi:10.3390/ijms25020990. This article has 3 citations.
(cunatova2024pathologicalvariantsin pages 11-12): Kristýna Čunátová and Erika Fernández‐Vizarra. Pathological variants in nuclear genes causing mitochondrial complex iii deficiency: an update. Journal of Inherited Metabolic Disease, 47:1278-1291, Jul 2024. URL: https://doi.org/10.1002/jimd.12751, doi:10.1002/jimd.12751. This article has 13 citations and is from a peer-reviewed journal.